Cargando…
Clinical Evidence for the Microbiome in Inflammatory Diseases
Clinical evidence is accumulating for a role of the microbiome in contributing to or modulating severity of inflammatory diseases. These studies can be organized by various organ systems involved, as well as type of study approach utilized, whether investigators compared the microbiome of cases vers...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388779/ https://www.ncbi.nlm.nih.gov/pubmed/28446909 http://dx.doi.org/10.3389/fimmu.2017.00400 |
_version_ | 1782521177000902656 |
---|---|
author | Slingerland, Ann E. Schwabkey, Zaker Wiesnoski, Diana H. Jenq, Robert R. |
author_facet | Slingerland, Ann E. Schwabkey, Zaker Wiesnoski, Diana H. Jenq, Robert R. |
author_sort | Slingerland, Ann E. |
collection | PubMed |
description | Clinical evidence is accumulating for a role of the microbiome in contributing to or modulating severity of inflammatory diseases. These studies can be organized by various organ systems involved, as well as type of study approach utilized, whether investigators compared the microbiome of cases versus controls, followed patients longitudinally, or intervened with antibiotics, prebiotics, or bacterial introduction. In this review, we summarize the clinical evidence supporting the microbiome as an important mechanism in the onset and maintenance of inflammation. |
format | Online Article Text |
id | pubmed-5388779 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-53887792017-04-26 Clinical Evidence for the Microbiome in Inflammatory Diseases Slingerland, Ann E. Schwabkey, Zaker Wiesnoski, Diana H. Jenq, Robert R. Front Immunol Immunology Clinical evidence is accumulating for a role of the microbiome in contributing to or modulating severity of inflammatory diseases. These studies can be organized by various organ systems involved, as well as type of study approach utilized, whether investigators compared the microbiome of cases versus controls, followed patients longitudinally, or intervened with antibiotics, prebiotics, or bacterial introduction. In this review, we summarize the clinical evidence supporting the microbiome as an important mechanism in the onset and maintenance of inflammation. Frontiers Media S.A. 2017-04-12 /pmc/articles/PMC5388779/ /pubmed/28446909 http://dx.doi.org/10.3389/fimmu.2017.00400 Text en Copyright © 2017 Slingerland, Schwabkey, Wiesnoski and Jenq. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Slingerland, Ann E. Schwabkey, Zaker Wiesnoski, Diana H. Jenq, Robert R. Clinical Evidence for the Microbiome in Inflammatory Diseases |
title | Clinical Evidence for the Microbiome in Inflammatory Diseases |
title_full | Clinical Evidence for the Microbiome in Inflammatory Diseases |
title_fullStr | Clinical Evidence for the Microbiome in Inflammatory Diseases |
title_full_unstemmed | Clinical Evidence for the Microbiome in Inflammatory Diseases |
title_short | Clinical Evidence for the Microbiome in Inflammatory Diseases |
title_sort | clinical evidence for the microbiome in inflammatory diseases |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388779/ https://www.ncbi.nlm.nih.gov/pubmed/28446909 http://dx.doi.org/10.3389/fimmu.2017.00400 |
work_keys_str_mv | AT slingerlandanne clinicalevidenceforthemicrobiomeininflammatorydiseases AT schwabkeyzaker clinicalevidenceforthemicrobiomeininflammatorydiseases AT wiesnoskidianah clinicalevidenceforthemicrobiomeininflammatorydiseases AT jenqrobertr clinicalevidenceforthemicrobiomeininflammatorydiseases |